Human Genome Variation, Published online: 29 June 2026; doi:10.1038/s41439-026-00356-0 Functional evidence for SCN8A splice-donor variant c.4419+1 A > G causing loss of function
Takashi Shibata, Tomoyuki Akiyama, Takuma Harasaki, Sachiko Miyamoto, Hirotomo Saitsu, Toshiki Takenouchi. Functional evidence for SCN8A splice-donor variant c.4419+1 A > G causing loss of function. // Human Genome Variation. – 2026. – DOI: 10.1038/s41439-026-00356-0. – URL: https://www.nature.com/articles/s41439-026-00356-0
Takashi Shibata, Tomoyuki Akiyama, Takuma Harasaki, Sachiko Miyamoto, Hirotomo Saitsu, & Toshiki Takenouchi (2026). Functional evidence for SCN8A splice-donor variant c.4419+1 A > G causing loss of function. Human Genome Variation. https://doi.org/10.1038/s41439-026-00356-0
Takashi Shibata, et al. “Functional evidence for SCN8A splice-donor variant c.4419+1 A > G causing loss of function.” Human Genome Variation, 2026. doi:10.1038/s41439-026-00356-0.
@article{Shibata2026,
title = {Functional evidence for SCN8A splice-donor variant c.4419+1 A > G causing loss of function},
author = {Shibata, Takashi and Akiyama, Tomoyuki and Harasaki, Takuma and Miyamoto, Sachiko and Saitsu, Hirotomo and Takenouchi, Toshiki},
journal = {Human Genome Variation},
year = {2026},
doi = {10.1038/s41439-026-00356-0},
url = {https://www.nature.com/articles/s41439-026-00356-0}
}
Gene Therapy, Published online: 13 November 2026; doi:10.1038/s41434-026-00658-6 Clinical landscape of gene therapy for rare diseases: a registry-based analysis of clinical trials and FDA-approved products
Human Genome Variation, Published online: 12 November 2026; doi:10.1038/s41439-026-00361-3 Arthrogryposis involves multiple joint contractures present at birth, affecting both upper and lower extremities. This study investigates the...
Gene Therapy, Published online: 10 November 2026; doi:10.1038/s41434-026-00657-7 Perspectives on cell and gene therapy: insights from the 5th China Annual Congress on CGT
Gene Therapy, Published online: 04 November 2026; doi:10.1038/s41434-026-00649-7 High-resolution separation and quantification of dual-AAV drug products by density gradient equilibrium analytical ultracentrifugation
Gene Therapy, Published online: 03 November 2026; doi:10.1038/s41434-026-00656-8 Genotoxic safety and long-term engraftment dynamics of efficient translational CRISPR/Cas9 therapeutics for β-haemoglobinopathies from bench to clinical trials